Biomerica, Inc.
BMRA
$2.38
-$0.02-0.63%
NASDAQ
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.46M | 4.88M | 5.31M | 5.68M | 5.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.46M | 4.88M | 5.31M | 5.68M | 5.58M |
| Cost of Revenue | 4.21M | 4.25M | 4.81M | 4.91M | 4.98M |
| Gross Profit | 250.00K | 636.00K | 501.00K | 765.00K | 597.00K |
| SG&A Expenses | 4.64M | 4.58M | 4.61M | 4.83M | 5.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.72M | 9.77M | 10.45M | 10.78M | 11.47M |
| Operating Income | -5.27M | -4.89M | -5.14M | -5.10M | -5.89M |
| Income Before Tax | -4.02M | -3.65M | -4.97M | -4.85M | -5.59M |
| Income Tax Expenses | 9.00K | 1.00K | 2.00K | 4.00K | 12.00K |
| Earnings from Continuing Operations | -4.03 | -3.66 | -4.97 | -4.85 | -5.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.03M | -3.66M | -4.97M | -4.85M | -5.61M |
| EBIT | -5.27M | -4.89M | -5.14M | -5.10M | -5.89M |
| EBITDA | -5.18M | -4.80M | -5.05M | -5.01M | -5.80M |
| EPS Basic | -1.64 | -1.63 | -2.25 | -2.23 | -2.66 |
| Normalized Basic EPS | -1.02 | -1.02 | -1.41 | -1.39 | -1.66 |
| EPS Diluted | -1.67 | -1.66 | -2.29 | -2.24 | -2.67 |
| Normalized Diluted EPS | -1.02 | -1.02 | -1.41 | -1.39 | -1.66 |
| Average Basic Shares Outstanding | 10.15M | 9.38M | 8.85M | 8.75M | 8.45M |
| Average Diluted Shares Outstanding | 10.15M | 9.38M | 8.85M | 8.75M | 8.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |